收费全文 | 2048003篇 |
免费 | 148011篇 |
国内免费 | 3123篇 |
耳鼻咽喉 | 29345篇 |
儿科学 | 62223篇 |
妇产科学 | 57277篇 |
基础医学 | 295056篇 |
口腔科学 | 59648篇 |
临床医学 | 175760篇 |
内科学 | 400811篇 |
皮肤病学 | 42733篇 |
神经病学 | 159391篇 |
特种医学 | 80394篇 |
外国民族医学 | 438篇 |
外科学 | 324278篇 |
综合类 | 41587篇 |
现状与发展 | 2篇 |
一般理论 | 510篇 |
预防医学 | 144540篇 |
眼科学 | 47321篇 |
药学 | 158206篇 |
3篇 | |
中国医学 | 4301篇 |
肿瘤学 | 115313篇 |
2018年 | 19090篇 |
2016年 | 16327篇 |
2015年 | 18834篇 |
2014年 | 25809篇 |
2013年 | 38808篇 |
2012年 | 53210篇 |
2011年 | 56530篇 |
2010年 | 33521篇 |
2009年 | 31766篇 |
2008年 | 55075篇 |
2007年 | 59040篇 |
2006年 | 60106篇 |
2005年 | 58570篇 |
2004年 | 56567篇 |
2003年 | 54678篇 |
2002年 | 53835篇 |
2001年 | 102490篇 |
2000年 | 105728篇 |
1999年 | 89200篇 |
1998年 | 23159篇 |
1997年 | 20590篇 |
1996年 | 20809篇 |
1995年 | 19523篇 |
1994年 | 18396篇 |
1993年 | 17008篇 |
1992年 | 70290篇 |
1991年 | 68320篇 |
1990年 | 66881篇 |
1989年 | 65124篇 |
1988年 | 60288篇 |
1987年 | 58821篇 |
1986年 | 55682篇 |
1985年 | 53192篇 |
1984年 | 38892篇 |
1983年 | 33470篇 |
1982年 | 18834篇 |
1981年 | 16565篇 |
1979年 | 35894篇 |
1978年 | 24808篇 |
1977年 | 21421篇 |
1976年 | 19563篇 |
1975年 | 21504篇 |
1974年 | 25661篇 |
1973年 | 24440篇 |
1972年 | 23343篇 |
1971年 | 21855篇 |
1970年 | 20526篇 |
1969年 | 19665篇 |
1968年 | 18241篇 |
1967年 | 16128篇 |
Areas covered: This review includes a view of the clinical classification and risk assessment in children suffering from HL. The chemotherapy more commonly employed is revisited. The use of PET/CT to evaluate the disease in order to guide therapy is analyzed. New options of chemotherapy and emerging immunotherapy are also included.
Expert opinion: In order to make the right treatment choice, a proper initial assessment of risk is mandatory. The choice of therapy in these kinds of patients must be done according to the experience of the team, and also, the cost and logistics related to the eligible scheme are very important. If possible, efforts must be made to include PET/CT in guiding therapy and avoiding overtreatment and long-term adverse effects in children. New options in immunotherapy are emerging and must be considered with caution in selected patients. 相似文献
Methods: Two previously published datasets (n?=?153 and n?=?641, respectively) from outpatient neuropsychological evaluations were used to test Dunham and Denney’s algorithm, and to assess concordance of failure rates with the Test of Memory Malingering and the forced choice measure of the California Verbal Learning Test, two commonly used performance validity tests.
Results: In both datasets, none of the four cutoff scores for failure on the MSVT (70%, 75%, 80%, or 85%) identified a poor validity group with proportionally aligned failure rates on other freestanding measures of performance validity. Additionally, the protocols with probable impairment did not differ from those with poor validity on cognitive measures.
Conclusions: Despite what appeared to be a promising approach to evaluating failure on the easy MSVT subtests when clinical data are unavailable (as recommended in the advanced interpretation program, or advanced interpretation [AI], of the MSVT), the current findings indicate the AI remains the gold standard for doing so. Future research should build on this effort to address shortcomings in measures of effort in neuropsychological evaluations. 相似文献